Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection.

A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection. To determine the pharmacokinetic properties, tolerance, safety, and preliminary activity of stavudine in human immunodeficiency virus (HIV)-infected children. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pediatrics Pubmed

A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection.

Download PDF

A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection.


Abstract

To determine the pharmacokinetic properties, tolerance, safety, and preliminary activity of stavudine in human immunodeficiency virus (HIV)-infected children.

Loading next page...
 
/lp/pubmed/a-phase-i-ii-evaluation-of-stavudine-d4t-in-children-with-human-raUffbCpbH

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0031-4005
pmid
7630678

Abstract

To determine the pharmacokinetic properties, tolerance, safety, and preliminary activity of stavudine in human immunodeficiency virus (HIV)-infected children.

Journal

Pediatrics – Pubmed

Published: Sep 5, 1995

There are no references for this article.